Table 1.
Characteristic | BMI (kg/m2) | P Value | |||||
---|---|---|---|---|---|---|---|
<18.5 | 18.5–24.9 | 25–29.9 | 30–34.9 | 35–39.9 | ≥40 | ||
Patients (n) | 54,398 | 222,237 | 194,436 | 116,968 | 60,700 | 53,717 | |
Age (yr), mean±SD | 61±19 | 64±17 | 63±15 | 61±14 | 59±14 | 57±13 | <0.001 |
Men | 49 | 58 | 58 | 51 | 56 | 63 | <0.001 |
Race | <0.001 | ||||||
White | 62 | 66 | 67 | 65 | 62 | 59 | |
Black | 31 | 26 | 28 | 30 | 34 | 37 | |
Other | 7 | 8 | 5 | 5 | 4 | 4 | |
Inability to ambulate | 6 | 5 | 4 | 4 | 5 | 7 | <0.001 |
Insurance | <0.001 | ||||||
Medicare/Medicaid | 85 | 82 | 81 | 79 | 78 | 78 | |
Private | 2 | 4 | 5 | 6 | 7 | 8 | |
Other | 3 | 6 | 6 | 7 | 7 | 6 | |
No insurance | 10 | 8 | 8 | 8 | 8 | 8 | |
Cause of ESRD | <0.001 | ||||||
Diabetes | 32 | 36 | 47 | 55 | 60 | 60 | |
Hypertension | 33 | 32 | 26 | 22 | 19 | 19 | |
Glomerular | 10 | 9 | 9 | 8 | 8 | 9 | |
Polycystic disease | 2 | 3 | 3 | 2 | 2 | 2 | |
Other | 23 | 20 | 15 | 13 | 11 | 10 | |
History of comorbid conditions | |||||||
Ischemic heart disease | 21 | 24 | 25 | 24 | 23 | 20 | <0.001 |
Cerebrovascular disease | 10 | 10 | 9 | 9 | 8 | 7 | <0.001 |
Congestive heart failure | 30 | 31 | 32 | 34 | 35 | 37 | <0.001 |
Peripheral vascular disease | 15 | 15 | 14 | 14 | 14 | 13 | <0.001 |
Cancer | 6 | 7 | 6 | 5 | 5 | 4 | <0.001 |
Year of first ESRD treatment | <0.001 | ||||||
1995–1999 | 60 | 34 | 29 | 25 | 23 | 20 | |
2000–2003 | 22 | 35 | 36 | 36 | 35 | 35 | |
2004–2007 | 18 | 31 | 35 | 39 | 42 | 45 | |
RUCA group | <0.001 | ||||||
Metropolitan | 80 | 81 | 80 | 78 | 77 | 77 | |
Micropolitan | 10 | 11 | 10 | 12 | 12 | 12 | |
Rural | 10 | 9 | 10 | 11 | 11 | 11 |
Data are given in percentages unless otherwise indicated. The frequency of missing data was as follows: data on age, race, cause of ESRD, ambulatory status, and comorbid conditions were missing in <1%; data on insurance were missing in 2%. BMI, body mass index; RUCA, rural urban commuting area codes.